Application 212839
- Type
- NDA
- Sponsor
- SK LIFE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | XCOPRI | CENOBAMATE | TABLET;ORAL | 12.5MG | Yes | No |
| 002 | XCOPRI | CENOBAMATE | TABLET;ORAL | 25MG | Yes | No |
| 003 | XCOPRI | CENOBAMATE | TABLET;ORAL | 50MG | Yes | No |
| 004 | XCOPRI | CENOBAMATE | TABLET;ORAL | 100MG | Yes | No |
| 005 | XCOPRI | CENOBAMATE | TABLET;ORAL | 150MG | Yes | No |
| 006 | XCOPRI | CENOBAMATE | TABLET;ORAL | 200MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N212839-001 | XCOPRI | CENOBAMATE | 12.5MG | TABLET / ORAL | RLD, RS | 2020-03-10 | |
| N212839-002 | XCOPRI | CENOBAMATE | 25MG | TABLET / ORAL | RLD | 2020-03-10 | |
| N212839-003 | XCOPRI | CENOBAMATE | 50MG | TABLET / ORAL | RLD | 2020-03-10 | |
| N212839-004 | XCOPRI | CENOBAMATE | 100MG | TABLET / ORAL | RLD | 2020-03-10 | |
| N212839-005 | XCOPRI | CENOBAMATE | 150MG | TABLET / ORAL | RLD | 2020-03-10 | |
| N212839-006 | XCOPRI | CENOBAMATE | 200MG | TABLET / ORAL | RLD | 2020-03-10 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N212839-001 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | |
| N212839-001 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | |
| N212839-002 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | |
| N212839-002 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | |
| N212839-003 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | |
| N212839-003 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | |
| N212839-004 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | |
| N212839-004 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | |
| N212839-005 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | |
| N212839-005 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | |
| N212839-006 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | |
| N212839-006 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N212839-001 | XCOPRI | 12.5MG | TABLET / ORAL | RLD, RS | 2020-03-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212839-002 | XCOPRI | 25MG | TABLET / ORAL | RLD | 2020-03-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212839-003 | XCOPRI | 50MG | TABLET / ORAL | RLD | 2020-03-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212839-004 | XCOPRI | 100MG | TABLET / ORAL | RLD | 2020-03-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212839-005 | XCOPRI | 150MG | TABLET / ORAL | RLD | 2020-03-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212839-006 | XCOPRI | 200MG | TABLET / ORAL | RLD | 2020-03-10 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N212839-001 | XCOPRI | 12.5MG | TABLET / ORAL | RLD, RS | 2020-03-10 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212839-002 | XCOPRI | 25MG | TABLET / ORAL | RLD | 2020-03-10 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212839-003 | XCOPRI | 50MG | TABLET / ORAL | RLD | 2020-03-10 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212839-004 | XCOPRI | 100MG | TABLET / ORAL | RLD | 2020-03-10 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212839-005 | XCOPRI | 150MG | TABLET / ORAL | RLD | 2020-03-10 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212839-006 | XCOPRI | 200MG | TABLET / ORAL | RLD | 2020-03-10 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212839-001 | XCOPRI | 12.5MG | TABLET / ORAL | RLD, RS | 2020-03-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212839-002 | XCOPRI | 25MG | TABLET / ORAL | RLD | 2020-03-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212839-003 | XCOPRI | 50MG | TABLET / ORAL | RLD | 2020-03-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212839-004 | XCOPRI | 100MG | TABLET / ORAL | RLD | 2020-03-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212839-005 | XCOPRI | 150MG | TABLET / ORAL | RLD | 2020-03-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212839-006 | XCOPRI | 200MG | TABLET / ORAL | RLD | 2020-03-10 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212839-001 | XCOPRI | 12.5MG | TABLET / ORAL | RLD, RS | 2020-03-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212839-002 | XCOPRI | 25MG | TABLET / ORAL | RLD | 2020-03-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212839-003 | XCOPRI | 50MG | TABLET / ORAL | RLD | 2020-03-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212839-004 | XCOPRI | 100MG | TABLET / ORAL | RLD | 2020-03-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212839-005 | XCOPRI | 150MG | TABLET / ORAL | RLD | 2020-03-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212839-006 | XCOPRI | 200MG | TABLET / ORAL | RLD | 2020-03-10 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212839-001 | XCOPRI | 12.5MG | TABLET / ORAL | RLD, RS | 2020-03-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212839-002 | XCOPRI | 25MG | TABLET / ORAL | RLD | 2020-03-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212839-003 | XCOPRI | 50MG | TABLET / ORAL | RLD | 2020-03-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212839-004 | XCOPRI | 100MG | TABLET / ORAL | RLD | 2020-03-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212839-005 | XCOPRI | 150MG | TABLET / ORAL | RLD | 2020-03-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212839-006 | XCOPRI | 200MG | TABLET / ORAL | RLD | 2020-03-10 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212839-001 | XCOPRI | 12.5MG | TABLET / ORAL | RLD, RS | 2020-03-10 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212839-002 | XCOPRI | 25MG | TABLET / ORAL | RLD | 2020-03-10 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212839-003 | XCOPRI | 50MG | TABLET / ORAL | RLD | 2020-03-10 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212839-004 | XCOPRI | 100MG | TABLET / ORAL | RLD | 2020-03-10 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212839-005 | XCOPRI | 150MG | TABLET / ORAL | RLD | 2020-03-10 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212839-006 | XCOPRI | 200MG | TABLET / ORAL | RLD | 2020-03-10 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212839-001 | XCOPRI | 12.5MG | TABLET / ORAL | RLD, RS | 2020-03-10 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212839-002 | XCOPRI | 25MG | TABLET / ORAL | RLD | 2020-03-10 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212839-003 | XCOPRI | 50MG | TABLET / ORAL | RLD | 2020-03-10 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212839-004 | XCOPRI | 100MG | TABLET / ORAL | RLD | 2020-03-10 | b8a1b40f171c… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N212839-001 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212839-001 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212839-002 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212839-002 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212839-003 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212839-003 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212839-004 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212839-004 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212839-005 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212839-005 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212839-006 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212839-006 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N212839-001 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212839-001 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212839-002 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212839-002 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212839-003 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212839-003 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212839-004 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212839-004 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212839-005 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212839-005 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212839-006 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212839-006 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212839-001 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212839-001 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212839-002 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212839-002 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212839-003 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212839-003 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212839-004 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212839-004 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212839-005 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212839-005 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212839-006 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212839-006 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212839-001 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212839-001 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212839-002 | 7598279 | 2032-10-30 | Drug substance | 2020-03-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212839-002 | 11654133 | 2039-06-16 | U-3610 | 2023-05-31 | 31067a03dcf5… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212839-001 | NCE | 2025-03-10 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212839-002 | NCE | 2025-03-10 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212839-003 | NCE | 2025-03-10 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212839-004 | NCE | 2025-03-10 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212839-005 | NCE | 2025-03-10 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212839-006 | NCE | 2025-03-10 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N212839-001 | NCE | 2025-03-10 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212839-002 | NCE | 2025-03-10 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212839-003 | NCE | 2025-03-10 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212839-004 | NCE | 2025-03-10 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212839-005 | NCE | 2025-03-10 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212839-006 | NCE | 2025-03-10 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212839-001 | NCE | 2025-03-10 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212839-002 | NCE | 2025-03-10 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212839-003 | NCE | 2025-03-10 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212839-004 | NCE | 2025-03-10 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212839-005 | NCE | 2025-03-10 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212839-006 | NCE | 2025-03-10 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212839-001 | NCE | 2025-03-10 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212839-002 | NCE | 2025-03-10 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212839-003 | NCE | 2025-03-10 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212839-004 | NCE | 2025-03-10 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212839-005 | NCE | 2025-03-10 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212839-006 | NCE | 2025-03-10 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212839-001 | NCE | 2025-03-10 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212839-002 | NCE | 2025-03-10 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212839-003 | NCE | 2025-03-10 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212839-004 | NCE | 2025-03-10 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212839-005 | NCE | 2025-03-10 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212839-006 | NCE | 2025-03-10 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212839-001 | NCE | 2025-03-10 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212839-002 | NCE | 2025-03-10 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212839-003 | NCE | 2025-03-10 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212839-004 | NCE | 2025-03-10 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212839-005 | NCE | 2025-03-10 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212839-006 | NCE | 2025-03-10 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212839-001 | NCE | 2025-03-10 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212839-002 | NCE | 2025-03-10 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212839-003 | NCE | 2025-03-10 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212839-004 | NCE | 2025-03-10 | 5bbf6a4d5a75… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Xcopri | CENOBAMATE | SK Life Science, Inc. | 565c2126-57ae-4e29-b443-723bbe7e2072 | 2025-08-25 | Warnings, Adverse reactions | 212839 NDA212839 71699-050 71699-104 71699-103 71699-200 71699-150 71699-100 71699-201 71699-202 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 71699-050 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-050 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-050 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-050 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-050 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-050 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-050 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-050 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-050 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-050 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-100 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-100 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-100 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-100 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-100 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-100 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-100 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-100 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-100 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-100 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-102 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-102 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-102 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-102 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-102 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-102 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-102 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-102 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-102 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-103 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-103 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-103 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-103 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-103 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-103 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-103 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-103 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-103 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-103 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-104 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-104 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-104 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-104 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-104 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-104 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-104 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-150 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-150 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-150 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-150 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-150 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-150 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-150 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-150 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-150 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-150 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-200 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-200 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-200 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-200 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-200 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-200 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-200 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-200 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-200 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-200 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-201 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-201 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-201 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-201 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-201 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-201 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-201 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-201 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-201 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-202 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-202 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-202 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-202 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
| 71699-202 | Xcopri | cenobamate | SK Life Science, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 83157 | SUPPL | 2025-08-20 |
| 83156 | SUPPL | 2025-08-20 |
| 83135 | SUPPL | 2025-08-19 |
| 78102 | SUPPL | 2024-04-09 |
| 78101 | SUPPL | 2024-04-09 |
| 78100 | SUPPL | 2024-04-09 |
| 78086 | SUPPL | 2024-04-08 |
| 78085 | SUPPL | 2024-04-08 |
| 77350 | SUPPL | 2024-01-29 |
| 77324 | SUPPL | 2024-01-29 |
| 71487 | SUPPL | 2022-06-30 |
| 71486 | SUPPL | 2022-06-30 |
| 71485 | SUPPL | 2022-06-30 |
| 71463 | SUPPL | 2022-06-28 |
| 71462 | SUPPL | 2022-06-28 |
| 68933 | ORIG | 2021-10-08 |
| 64496 | SUPPL | 2020-09-04 |
| 64495 | SUPPL | 2020-09-04 |
| 64468 | SUPPL | 2020-09-01 |
| 61220 | ORIG | 2019-12-10 |
| 61020 | ORIG | 2019-11-22 |
| 61019 | ORIG | 2019-11-22 |